I. [Product Description]
PLGA NPs-CD-β-HP-2-FF Polylactic-glycolic acid copolymer-hydroxypropyl beta-cyclodextrin modified florfenicol is an important organic intermediate with good chemical stability and modification properties, and has high application value in the field of organic synthesis.

II. [Product Details]
【Appearance】 Depending on different molecular weights, it appears as a white/off-white solid or a viscous liquid.
【Stability】 Store under refrigeration and avoid repeated freezing and thawing.
【Solvent】 Conventional organic solvents such as chloroform and DMSO.
【Storage Conditions】 Store in a low-temperature, sealed and dry environment below 4°C.
▪ Note: ▶ To ensure product stability, please open the package for use only after constant-temperature drying!

III. [Application Areas]
1. It can be used as an intermediate in the synthesis reaction of organic compounds.
2. It has certain applications in the modification of polymer materials.
3. It is used as an additive to improve the properties of certain materials.
4. It is used in the preparation of specific chemicals in the field of fine chemicals.

Remarks: The products sold by our company are only used for scientific research and cannot be used in human experiments or human treatment.

Chongqing Yusi Pharmaceutical Technology Co., Ltd. is based on an integrated business model of independent R & D-production-sales, providing professional scientific research reagents for scientific research experiments in universities. Compared with similar products on the market, our company's products have obvious price advantages. In addition, we also provide professional product customization services.

If you need other products, please contact us:
Contact Information:
Landline: 023-62795528
Customer Service Hotline: 19923757617 丨 QQ: 3279537175
                                           19112925095 丨 QQ: 3012135199

Similar Product Recommendations:
1. PLGA NPs-CD-β-HP-3-FF Polylactic-glycolic acid copolymer-hydroxypropyl beta-cyclodextrin modified florfenicol
2. PLGA NPs-CD-β-HP-1-FF Polylactic-glycolic acid copolymer-hydroxypropyl beta-cyclodextrin modified florfenicol
3. PLGA NPs-CD-α-HP-2-FF Polylactic-glycolic acid copolymer-hydroxypropyl alpha-cyclodextrin modified florfenicol
4. PLGA NPs-CD-γ-HP-2-FF Polylactic-glycolic acid copolymer-hydroxypropyl gamma-cyclodextrin modified florfenicol
5. PLGA NPs-CD-β-2-FF Polylactic-glycolic acid copolymer-beta-cyclodextrin modified florfenicol
6. PLGA NPs-CD-β-HP-2-Chloramphenicol Polylactic-glycolic acid copolymer-hydroxypropyl beta-cyclodextrin modified chloramphenicol
7. PLGA NPs-CD-β-HP-2-Tetracycline Polylactic-glycolic acid copolymer-hydroxypropyl beta-cyclodextrin modified tetracycline
8. PLGA NPs-CD-β-HP-2-Erythromycin Polylactic-glycolic acid copolymer-hydroxypropyl beta-cyclodextrin modified erythromycin
9. PLGA NPs-CD-β-HP-2-Gentamicin Polylactic-glycolic acid copolymer-hydroxypropyl beta-cyclodextrin modified gentamicin
10. PLGA NPs-CD-β-HP-2-Streptomycin Polylactic-glycolic acid copolymer-hydroxypropyl beta-cyclodextrin modified streptomycin
11. PLGA NPs-CD-β-HP-2-Kanamycin Polylactic-glycolic acid copolymer-hydroxypropyl beta-cyclodextrin modified kanamycin
12. PLGA NPs-CD-β-HP-2-Neomycin Polylactic-glycolic acid copolymer-hydroxypropyl beta-cyclodextrin modified neomycin